N/A
Completed N=14,064
Telephone-Based Program to Promote Inhaled Corticosteroid Adherence Among Individuals With Asthma
Source: ClinicalTrials.gov NCT00414817 ↗Enrolled (actual)
14,064
Serious AEs
0.0%
Results posted
Jan 2017
Primary outcomePrimary: Modified Medication Possession Ratio — .40; .38 fraction of days with medication — p=.002
Summary
Inhaled corticosteroids (ICS) are often prescribed as a treatment for asthma. However, many individuals who take these medications do not adhere to their prescribed treatment regimen. The purpose of this study is to evaluate the effectiveness of a telephone-based program at improving medication adherence among individuals with asthma.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Modified Medication Possession Ratio |
.40; .38 | .002 sig |
| SECONDARY Juniper Asthma Quality of Life Questionnaire (Global Score) |
4.8; 4.9 | 0.175 |
| SECONDARY Rate of Acute Health Care Visits for Asthma |
1.7; 1.7 | 0.852 |
Eligibility Criteria
Inclusion Criteria
- Received treatment for asthma in the year prior to study entry
- Received at least one respiratory medication at a Kaiser Permanente Northwest (KPNW) or Kaiser Permanente Hawaii (KPH) outpatient pharmacy in the year prior to study entry
- Continuous Kaiser Permanente membership from the year prior to study entry through study entry
- Willing to participate in the study
Exclusion Criteria
- Excluded from primary analyses if fewer than three months of follow-up
Data sourced from ClinicalTrials.gov (NCT00414817). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.